-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics Reports Positive 12-Week Phase 1b PIONEER Trial Results for Pociredir in Sickle Cell Disease

Reuters·02/24/2026 12:03:56

Please log in to view news